MedCrypt provides security products and services. It offers solutions for medical device manufacturers, startups, and mid-sized companies, including manufacturers of surgical robotics technologies and virtual reality applications for minimally invasive surgery. It offers cybersecurity products and strategic management consulting to expedite the go-to-market process of medical device manufacturers. The company was founded in 2016 and is based in Solana Beach, California.
MedCrypt's Product Videos
ESPs containing MedCrypt
The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.
The IoT security market is focused on addressing the security challenges presented by the rapidly growing number of connected devices, including managed, unmanaged, network connected, airspace connected, IT, OT, IoT and IoMT devices. The expanded attack surface created by this diversity of assets is a major concern for organizations as they struggle to maintain complete visibility of their environ…
MedCrypt's Products & Differentiators
Expert Collections containing MedCrypt
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
MedCrypt is included in 2 Expert Collections, including Cybersecurity.
These companies protect organizations from digital threats.
The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.
Latest MedCrypt News
Sep 18, 2023
The pair will work on a project to quantify regulatory and cybersecurity risks in the medical field. Michael Barbella, Managing Editor09.18.23 MedCrypt Inc. has teamed up with Kansas State University (K-State) by providing a grant to drive advancements in quantifying regulatory and cybersecurity risk in the medical field. The partnership will aim to enhance medical device cybersecurity research by focusing on validating the tools used to assess client risk, incorporating a holistic approach, and seamlessly integrating technical elements and public and regulatory policy considerations. The collaboration, led by Dr. Eugene Vasserman (K-State) and Dr. Seth Carmody, MedCrypt's vice president of Regulatory Strategy, aims to address the varied challenges of assessing and quantifying cybersecurity risks associated with interconnected medical devices and their impact on clinical care delivery, patient safety, and business continuity. The MedCrypt and K-State collaboration brings together premier research institutions to tackle challenging problems faced by medical device manufacturers (MDMs). Additionally, it provides the possibility for working together between MedCrypt, K-State, and Tufts University . With the U.S. Food and Drug Administration's (FDA's) decision to refuse future device submissions which don't meet minimal cybersecurity requirements by Oct. 1, there is a call to action for MDMs to prioritize cybersecurity. The research will combine a comprehensive qualitative and quantitative approach that considers risks from both business and technical perspectives. Unlike prior "one size fits all" work, which includes analyzing the manufacturer-specific approach to cybersecurity during product line engineering and product design, product requirement and risk evaluation including compensating controls, verification and validation procedures, and post-market monitoring and support. By integrating broader cybersecurity practices such as threat modeling, vulnerability monitoring, and incident response, MedCrypt and K-State can work towards enhancing the security posture of medical devices and manufacturers. The urgency to comply with the FDA's requirements provides a compelling incentive for MDMs to engage with MedCrypt. Through the partnership, MedCrypt and K-State can leverage academic best practices in medical device cybersecurity while applying real-life constraints that MDMs experience every day. By doing so, they will contribute to the overall safety and integrity of interconnected medical devices, ultimately improving patient care, reducing the risk of cyber threats in healthcare environments, and placing MDM-level cybersecurity risk estimation on a firmer footing. "Partnering with Kansas State University allows us to focus on a critical research initiative," Carmody said. "This partnership validates the value of our risk assessment tools and strengthens our capacity to tackle evolving challenges in medical device cybersecurity. By leveraging academic expertise, industry insights, and an understanding of new rules and regulations, we are confident that our joint efforts will lead to significant advancements." Dr. Vasserman brings extensive experience in the security of distributed systems, cyber-physical systems, and the socio-technical aspects of security. As the director of the Kansas State University Center for Cybersecurity and Trustworthy Systems (K-CaTS) , he has played a pivotal role in advancing cybersecurity education and has been involved in multiple medical device cybersecurity projects, from the MDM side as well as through collaboration with the FDA. Dr. Vasserman has also received several notable recognitions, including the Commissioner's Special Citation in 2018 as a member of the St. Jude Medical Cybersecurity Response Team, the Outstanding Service Award in 2020 as a member of the Cardiac Monitor Cybersecurity Review Team, and the Group Recognition Award in the same year as a member of the URGENT/11 Response Team. "I am honored to lead this research and work closely with MedCrypt to address challenges in medical device cybersecurity," Vasserman stated. "Our research will not only provide a holistic understanding of cybersecurity risk in the medical field but also contribute to developing standards and policies that will help strengthen the safety and integrity of medical devices. Together, we aim to make lasting improvements to the industry and protect patients from ever-evolving cyber threats." The research team will develop a platform that is both customizable and expandable, integrating qualitative and quantitative metrics. This platform will provide actionable and prioritized recommendations for addressing current and future technological, regulatory, and business risks. In terms of advancing science, the project will result in research papers and software artifacts that disseminate new knowledge and provide a foundation for others to build upon. Customers of MedCrypt can anticipate a swift integration of research findings into their products and services. This integration will bring immediate benefits, such as significantly enhanced proactive risk management, specifically tailored to the processes and needs of MDMs, which will include ongoing monitoring, testing, and updating of security controls. These practices not only help meet regulatory requirements but also effectively reduce cybersecurity risks while simultaneously lowering costs by prioritizing the mitigation strategies most likely to be effective and avoiding those that may yield little long-term benefit. MedCrypt is helping healthcare technology companies ensure medical devices are secure by design. The firm provides cybersecurity products and strategic management consulting to expedite the go-to-market process of medical device manufacturers' new life-saving connected technologies. Founded in 2016 by a team of healthcare cybersecurity experts, MedCrypt is positioned to be the security catalyst for medical device manufacturers to design secure, FDA-approved technologies. To date, MedCrypt has raised more than $36 million in funding with participation from Johnson & Johnson Innovations, Intuitive Ventures, and Dexcom Ventures.
MedCrypt Frequently Asked Questions (FAQ)
When was MedCrypt founded?
MedCrypt was founded in 2016.
Where is MedCrypt's headquarters?
MedCrypt's headquarters is located at 101 South Highway 101, Solana Beach.
What is MedCrypt's latest funding round?
MedCrypt's latest funding round is Series B - II.
How much did MedCrypt raise?
MedCrypt raised a total of $33.4M.
Who are the investors of MedCrypt?
Investors of MedCrypt include Dexcom Ventures, Eniac Ventures, Section 32, Dolby Family Ventures, Alumni Ventures and 12 more.
Who are MedCrypt's competitors?
Competitors of MedCrypt include Asimily and 5 more.
What products does MedCrypt offer?
MedCrypt's products include Guardian and 4 more.
Compare MedCrypt to Competitors
Ordr provides enterprises with visibility and control over every class of network-connected devices and systems. It is a purpose-built solution to fully map the device flow genome at scale, using machine learning to continuously inspect, classify and baseline the behavior of every device. The company was founded in 2015 and is based in Santa Clara, California.
Armis develops an asset intelligence and security platform. The platform helps protect devices such as laptops and smartphones, smart televisions (TVs), webcams, printers, industrial robots, medical devices, and more. It offers cyber asset attack surface management solutions, medical device security solutions, operational technology asset management solutions, and more. The company serves healthcare, manufacturing, retail, and other industries. It was founded in 2015 and is based in San Francisco, California.
Cylera operates as a cybersecurity company. It offers asset management, risk analysis, smart segmentation, threat defense, compliance and risk governance, and more. The company's insights and recommendations simplify response playbooks when incidents arise and decrease the time to remediate and enable informed decision-making. It was founded in 2017 and is based in New York, New York.
MedSec is a cyber security research company exclusively serving the health care industry, offering security assessment services and solutions to healthcare manufacturers and providers.
Asimily provides comprehensive monitoring for perspective maintenance and cyber-security across devices and vendors. Asimily’s IoMT risk remediation platform holistically secures mission-critical healthcare devices from cyberattacks for delivering safe and reliable care. It was founded in 2017 and is based in Sunnyvale, California.
Forescout delivers automated cybersecurity solutions through an integrated platform. Its solutions include risk and exposure management, Internet of Things (IoT) security, asset inventory management, medical device security, and more. It serves financial services, government, healthcare, energy and utilities and education industries. The company was founded in 2000 and is based in San Jose, California.